AI-Enhanced Probiotic Microvesicles for Personalized Therapeutics
Legal Citation
Summary of the Inventive Concept
The present invention integrates therapeutic microvesicles of probiotic bacteria with cutting-edge technologies like AI, IoT, blockchain, and novel materials to create a more powerful and personalized system for various health applications.
Background and Problem Solved
The original patent disclosed therapeutic microvesicles of probiotic bacteria, but its limitations include the lack of optimized therapeutic effect, inefficient production processes, and inadequate tracking and authentication mechanisms. The new inventive concept addresses these limitations by incorporating machine learning algorithms, IoT sensors, blockchain-based tracking, and novel materials to enhance the stability and bioavailability of the microvesicles.
Detailed Description of the Inventive Concept
The system comprises a therapeutic microvesicle of a probiotic bacteria, generated using a machine learning algorithm to optimize its therapeutic effect. The microvesicle production process involves culturing the probiotic bacteria in a growth medium, monitored by an IoT sensor to adjust the medium and optimize the production. The microvesicle is coated with a novel material to enhance its stability and bioavailability. A blockchain-based tracking system ensures the authenticity and integrity of the microvesicle. An AI-powered diagnostic tool identifies the specific health needs of a subject and tailors the microvesicle to those needs, enabling personalized medicine.
Novelty and Inventive Step
The new claims introduce the novel combination of machine learning algorithms, IoT sensors, blockchain-based tracking, and novel materials, which are not obvious from the original patent. The integration of these distinct technologies with the therapeutic microvesicles of probiotic bacteria provides a non-obvious and innovative solution.
Alternative Embodiments and Variations
Alternative embodiments may include using different AI algorithms, IoT sensors, or novel materials. Variations may involve integrating the system with other health-related technologies, such as wearables or telemedicine platforms, to further enhance its capabilities.
Potential Commercial Applications and Market
The AI-enhanced probiotic microvesicles have vast commercial potential in the healthcare industry, particularly in personalized medicine, gut health, and immune system modulation. The system can be marketed to pharmaceutical companies, healthcare providers, and consumers seeking advanced therapeutic solutions.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biotechnology and microbial engineering, specifically focused on probiotic bacteria, microvesicle production, and therapeutic applications with expertise in bacterial strain manipulation, culture techniques, and biomedical technology integration
Person of Ordinary Skill (PHOSITA) Profile
A researcher or engineer with advanced degrees in microbiology, biotechnology, or bioengineering, possessing knowledge of probiotic bacteria cultivation, microvesicle generation, and emerging technologies in personalized medicine
Obviousness Rationale
A PHOSITA would recognize that integrating emerging technologies like machine learning, IoT sensors, and blockchain with existing probiotic microvesicle technologies represents a predictable extension of known biomedical engineering approaches. The source patent establishes a foundation of probiotic microvesicle production, which a skilled practitioner would naturally seek to optimize and enhance using contemporary technological tools. The proposed variations represent logical incremental improvements that would be obvious to implement given the state of biotechnology and personalized medicine research.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,582 |
|---|---|
| Title | Therapeutic microvesicles of probiotic bacteria |
| Assignee(s) | BioGaia AB |